63187-900 NDC - ISOSORBIDE MONONITRATE

Drug Information

  • Product NDC: 63187-900
  • Proprietary Name: isosorbide mononitrate
  • Non Proprietary Name: isosorbide mononitrate
  • Active Ingredient(s): 20 mg/1 ISOSORBIDE MONONITRATE
  • Administration Route(s): ORAL
  • Dosage Form(s): TABLET
  • Pharmacy Class(es): Nitrate Vasodilator [EPC]; Nitrates [CS]; Vasodilation [PE]

Labeler Information

Field Name Field Value
Labeler Name: Proficient Rx LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020215
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date:6/30/1993

Package Information

No. Package Code Package Description Billing Unit
163187-900-3030 TABLET in 1 BOTTLE (63187-900-30)EA
263187-900-6060 TABLET in 1 BOTTLE (63187-900-60)
363187-900-9090 TABLET in 1 BOTTLE (63187-900-90)

NDC Record

Field Name Field Value Definition
PRODUCT NDC63187-900 
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEisosorbide mononitrateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEisosorbide mononitrateThis is the date that the labeler indicates was the start of its marketing of the drug product.
DOSAGE FORM NAMETABLETThis is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/30/1993This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDA AUTHORIZED GENERICThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
APPLICATION NUMBERNDA020215This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEProficient Rx LPProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
SUBSTANCE NAMEISOSORBIDE MONONITRATEThis corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
ACTIVE NUMERATOR STRENGTH20 
ACTIVE INGRED UNITmg/1 
PHARM CLASSESNitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025